Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, Inc., a med tech company, discusses the role of AI in the future of wearable heart monitoring devices and the FDA-cleared “Bioflux,” Biotricity’s latest technology being used by cardiologists nationwide to remotely monitor their patient’s heart conditions.Early intervention not only can reduce hospital stays but save money and save lives.
Waqaas, the founder of Biotricity, is a serial entrepreneur, a former investment advisor and an expert in wireless communication technology. Academically, he was distinguished for his various innovative designs in digital, analog, embedded, and micro-electro-mechanical products. His work was published in various conferences such as IEEE and the National Communication Council.
Waqaas has held several high-level design positions in IBM, AMD, and Intel. His achievements have been numerous in both the technical and academic world. Coupled with this, Waqaas has vast experience in leading various groups through his board experience and executive roles within start-ups, mid-sized companies, and non-profits.
Waqaas has a dual Bachelor’s degree in Computer Engineering and Economics, a Master’s in Computer Engineering from Rochester Institute of Technology, and a Master’s in Business Administration from Henley Business School. He also holds a Doctorate in Business with a specialty in Transformative Innovations and Billion Dollar Markets.